Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Krishnan

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Trials|November 4, 2022
Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trialKyuwan Lee, Nitya Nathwani, Justin Shamunee, et al.
International Journal of Hematologic Oncology|October 11, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failurePaul G Richardson, Stephan A Grupp, Antonio Pagliuca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)Amrita Krishnan, Joycelynne M Palmer, John A Zaia, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetanArturo Molina, Amrita Krishnan, Henry Fung, et al.
Cytotherapy|May 10, 2017
Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosisMichael Rosenzweig, Ryan Urak, Miriam Walter, et al.
British Journal of Haematology|February 13, 2024
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trialRuta Brazauskas, Kathryn Flynn, Amrita Krishnan, et al.
JMIR Mhealth and Uhealth|May 21, 2026
mHealth-Supported Exercise Rehabilitation to Reverse Frailty After Autologous Transplantation in Multiple Myeloma: Randomized Controlled TrialKyuwan Lee, Justin Shamunee, Haehyun Lee, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphomaAmrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2013
Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphomaAnthony R Cillo, Amrita Krishnan, Ronald T Mitsuyasu, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Trials|November 4, 2022
Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trialKyuwan Lee, Nitya Nathwani, Justin Shamunee, et al.
International Journal of Hematologic Oncology|October 11, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failurePaul G Richardson, Stephan A Grupp, Antonio Pagliuca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)Amrita Krishnan, Joycelynne M Palmer, John A Zaia, et al.
Current Stem Cell Research & Therapy|January 29, 2008
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetanArturo Molina, Amrita Krishnan, Henry Fung, et al.
Cytotherapy|May 10, 2017
Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosisMichael Rosenzweig, Ryan Urak, Miriam Walter, et al.
British Journal of Haematology|February 13, 2024
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trialRuta Brazauskas, Kathryn Flynn, Amrita Krishnan, et al.
JMIR Mhealth and Uhealth|May 21, 2026
mHealth-Supported Exercise Rehabilitation to Reverse Frailty After Autologous Transplantation in Multiple Myeloma: Randomized Controlled TrialKyuwan Lee, Justin Shamunee, Haehyun Lee, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphomaAmrita Krishnan, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2013
Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphomaAnthony R Cillo, Amrita Krishnan, Ronald T Mitsuyasu, et al.
Pageof 12